Fig. 1From: High preoperative serum sVCAM-1 concentration as a predictor of early ovarian cancer recurrenceComparison sVCAM-1 concentration in serum before operation in patients with relapse after 12 months or without relapse in the follow up period and in patients with disease progress or relapse in 12 months after the treatmentBack to article page